ホーム › 前立腺がん › コネチカット州 › New Haven
New Haven、CTにおける前立腺がんの臨床試験
New Havenとその周辺地域（約30マイル以内）の拠点で、前立腺がんに関する20件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
被験者募集中第1/2相
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
被験者募集中第2相
- Yale Cancer Center, New Haven
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
被験者募集中第1/2相
- Yale University, New Haven
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
被験者募集中第3相
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0064), New Haven
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
被験者募集中第1/2相
- GSK Investigational Site, New Haven
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
被験者募集中第2相
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven · 3マイル先
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
被験者募集中第3相
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0050), New Haven
- Veterans Affairs Connecticut Healthcare System ( Site 0062), West Haven · 3マイル先
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
被験者募集中第2相
- Yale Cancer Center, New Haven
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
被験者募集中第1相
- Yale Cancer Center, New Haven
A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth
被験者募集中観察研究
- Wren Laboratories, Branford · 6マイル先
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
被験者募集中第1相
- Yale New Haven Hospital, New Haven
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
被験者募集中第2相
- New Haven Hospital - Yale Cancer Center, New Haven
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Yale University School of Medicine, New Haven
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
被験者募集中第1相
- Yale New Haven Hospital, New Haven
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
被験者募集中第3相
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3マイル先
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
被験者募集中第1/2相
- Yale University (Data Collection Only), New Haven
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
被験者募集中観察研究
- Yale University, New Haven
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
被験者募集中第1/2相
- Yale University, Yale Cancer Center, New Haven
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
被験者募集中第2相
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7マイル先
- 他2件
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
被験者募集中第3相
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3マイル先
- Smilow Cancer Hospital Care Center - Guilford, Guilford · 13マイル先
他の都市における前立腺がんの試験
- New York City, NY103件の研究
- Houston, TX76件の研究
- Los Angeles, CA61件の研究
- Boston, MA59件の研究
- St. Louis, MO46件の研究
- Chicago, IL45件の研究
- San Francisco, CA45件の研究
- Philadelphia, PA44件の研究
- Baltimore, MD43件の研究
- Nashville, TN42件の研究
- Seattle, WA42件の研究
- Washington, DC38件の研究
New Havenにおける他の研究
- 非小細胞肺癌41件の研究
- 乳がん37件の研究
- がん（全種類）33件の研究
- 転移性癌23件の研究
- 肺がん22件の研究
- 頭頸部扁平上皮癌22件の研究
- 卵巣がん21件の研究
- 大腸癌20件の研究
- オピオイド過剰摂取18件の研究
- アルコール使用障害（AUD）17件の研究
- 急性骨髄性白血病17件の研究
- 膵臓がん16件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。